We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Artelon Metatarsophalangeal (MTP) Spacer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01028469
Recruitment Status : Unknown
Verified December 2009 by Artimplant AB.
Recruitment status was:  Recruiting
First Posted : December 9, 2009
Last Update Posted : December 15, 2009
Information provided by:

December 8, 2009
December 9, 2009
December 15, 2009
December 2009
December 2011   (Final data collection date for primary outcome measure)
Pain, function and alignment of the treated toe evaluated by the investigator using the American Orthopeadic Foot & Ankle Society (AOFAS) clinical rating system. [ Time Frame: pre-treatment and 12 months post-op ]
Same as current
Complete list of historical versions of study NCT01028469 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
Artelon Metatarsophalangeal (MTP) Spacer
Artelon MTP Spacer - Surgical Treatment of Mild to Moderate Hallux Rigidus
The aim of this prospective, case series is to evaluate the surgical treatment of painful and disabling osteoarthrosis in the MTP-I joint by insertion of an Artelon MTP Spacer.
Not Provided
Phase 4
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
  • Osteoarthritis
  • Hallux Rigidus
Device: Artelon MTP Spacer
Metatarsophalangeal hemi-implant
Experimental: Artelon MTP Spacer
Metatarsophalageal hemi-implant
Intervention: Device: Artelon MTP Spacer
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
Unknown status
Not Provided
December 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • The patient experiences pain and limitations of the great toe dorsiflexion at the MTP-I joint.
  • The patient has a clinically and radiographically verified arthritis in the MTP-I joint indicating the need for surgical treatment.
  • The patient reads, understands and is able to complete the study questionnaires in Swedish.
  • The patient has received written and oral information regarding the study and has signed the informed consent form.

Exclusion criteria:

  • The patient has a pronounced hallux rigidus without mobility in the MTP-I joint (ROM = 0°).
  • The patient has previously received surgical treatment affecting the anatomy of the MTP-I joint.
  • The patient has a systemic rheumatic disease, ongoing infection, hallux valgus or is seriously ill.
Sexes Eligible for Study: All
Child, Adult, Senior
Contact information is only displayed when the study is recruiting subjects
Not Provided
Not Provided
Katrin Gisselfalt, Chief Research & Development, Artimplant
Artimplant AB
Not Provided
Principal Investigator: Martin Alund, M.D. Sahlgrenska University Hospital, Mölndal, Sweden
Artimplant AB
December 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP